Concepedia

Staci Mellinger

SM

Statistics

Publications

6

Citations

87

H-Index

6

Active since

1987

Affiliations

Providence Portland Medical Center(Current)

Oregon Health & Science University

Cedars-Sinai Medical Center

University of California, Los Angeles

Sidney Kimmel Comprehensive Cancer Center

Staci Mellinger is an author at Providence Portland Medical Center specializing in cancer immunotherapy, pharmacology, and medicine.

Publications per year

1987–2019

6

Publications

6

Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.

Staci Mellinger, J. Kohler, Jennifer Dorsey et al. · PubMed · 1987 · 20 citations

, , +8

Pembrolizumab (pembro) with paclitaxel (taxol) or capecitabine (cape) as early treatment of metastatic triple-negative breast cancer (mTNBC).

David B. Page, Brie Chun, Joanna Pucilowska et al. · Journal of Clinical Oncology · 2019 · 19 citations

, , +16

Safety and efficacy of pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC).

David B. Page, Isaac K Kim, Katherine Sanchez et al. · Journal of Clinical Oncology · 2018 · 14 citations

, , +17

A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer

David B. Page, Joanna Pucilowska, Katherine Sanchez et al. · Clinical Cancer Research · 2019 · 12 citations · Full text

, , +17

Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count

DB Page, Joanna Pucilowska, Laura Bennetts et al. · Cancer Research · 2019 · 11 citations

, , +17

1–5 of 6